Impact of Marketing of Alcohol Products on Young People
NCT ID: NCT03818750
Last Updated: 2019-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2018-06-13
2019-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Alcohol Marketing Stimuli in Adults With Regular Alcohol Consumption
NCT05125783
Impact of a Brief Motivational Intervention Including Counter-marketing Arguments With a Population of Patients With Moderate to Severe Alcohol Use Disorders Who Are Followed up on an Outpatient Basis (Primary Care or Addictology) (DEPREV_Phase 3)
NCT04881500
Alcohol Early Intervention for Freshmen
NCT00852033
Campus Health Intervention Projects UBC Site
NCT00278733
Evaluation of AlcoholEdu for College
NCT01382979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In that regard, several measures are recommended by health actors to combat this issue: minimum unit pricing, sales ban to minor, low blood alcohol concentration for drivers, etc. A specific measure concerns alcohol advertising restrictions. Some countries implemented alcohol advertising regulation laws (Poland, Sweden, Finland, Estonia, etc.), including France with the Evin law passed in 1991. This French law mandates advertising (and packaging) content to strictly convey factual information and objective qualities of alcohol products and thus bans attractive ads based on image and lifestyle evocations (seduction, power, etc.).
The objective of this research is to investigate whether statutory framework for alcohol advertising (e.g., Evin law) can effectively protect people against misleading, suggestive, and appealing content. Little research has been conducted on this topic in spite of WHO's recommendations (most research has explored the influence of exposure to ads but not the impact of content).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental arm
Patients (60) will be selected from the Alcohol Use Disorders Identification Test (AUDIT-C) :
* "light drinkers" (score between 1 to 3)
* "heavy drinkers" (score between 4 to 7) Two clinical visits will be realized in less than 4 weeks
MRI
Subjects review alcohol ads in different contexts (neutral context vs positive context such as parties and sport) and answer with buttons lever while being in the MRI to express their desire to consume alcohol or not.
Subjects will be exposed to 288 ads set up.
Alcohol Use Disorders Identification Test
Questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
Subjects review alcohol ads in different contexts (neutral context vs positive context such as parties and sport) and answer with buttons lever while being in the MRI to express their desire to consume alcohol or not.
Subjects will be exposed to 288 ads set up.
Alcohol Use Disorders Identification Test
Questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18-25
* right-handed
* persons that consume alcohol : " light drinkers " or "heavy drinkers" (defined with the AUDIT scale, scores between 1 to 7)
* written consent and agreement consent will be given
* Affiliated to the French social insurance
Exclusion Criteria
* misuse of psychoactive products (except tobacco) (cannabis : no regular consumers -more than 10 times per month ; no users of other illicit drugs - even for occasional consumption)
* non fluent french speaking persons (people who couldn't understand instructions or asked questions)
* persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty
Related to the MRI:
* Cardiac pacemaker or implanted defibrillator
* Cochlear implant
* Peripheral or neuronal stimulator
* Intra-ocular or brain metallic foreign bodies
* Any other contraindications to MRI
18 Years
25 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ecole des Hautes Etudes en Santé Publique (EHESP)
UNKNOWN
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Romain Moirand, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU of Rennes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Rennes
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A00219-46
Identifier Type: OTHER
Identifier Source: secondary_id
35RC18_8845_IMAJ
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.